Details

Autor(en) / Beteiligte

• Puślecki, Łukasz
• Marek, Dąbrowski
• Michael, Czekajlo
• Mateusz, Puślecki
• Śliwiński, Rafał

Titel

Accelerating R&D with Knowledge and New Technological Solutions - From Innovation Cooperation to Translational Innovation

Ist Teil von

• Competition, Strategy, and Innovation, 2022, p.175-202

Auflage

1

Ort / Verlag

United Kingdom: Routledge

Erscheinungsjahr

2022

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• The main aim of this chapter is to verify how innovation cooperation can support the improvement of patient care, taking into consideration new technological solutions - digital Health, medHealth, mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine - and modern medical simulation. In addition, the authors present how such innovative cooperation should be developed in order to bring about appropriate results. The authors present examples of projects that use digital tools and artificial intelligence (AI) and which are focused on the delivery of new solutions to improve patient care. In order to deliver these solutions to the market faster, the role of innovation cooperation should not be forgotten. Taking this issue into account, the authors share the results of one of the first quantitative primary research projects in the world that focuses on innovation cooperation in the biopharmaceutical industry in the Central and Eastern Europe (CEE) region (covering 18 countries), as well as qualitative research: a focus group interview with representatives of the "ECMO (Extracorporeal Membrane Oxygenation) for Greater Poland" regarding the development of successful innovation cooperation as an example of translational innovation. Finally, the authors provide a translational innovation model that can be extrapolated to every industry, social, and economic area. This chapter aims to innovation cooperation can support the improvement of patient care, taking into consideration new technological solutions - digital Health, medHealth, mobile health, health information technology, wearable devices, telehealth and telemedicine, and personalized medicine - and modern medical simulation. Biopharmaceutical companies have developed cooperation with universities for many years. At the beginning, the cooperation mainly included individual, single projects from small research projects to large clinical trials. In 2020, the Covid-19 pandemic contributed to the development of new strategic partnerships in the biopharmaceutical industry, including via use of open models. The pandemic emphasized the need for high-quality data, digital health technologies, and AI analytics tools. However, despite these historical breakthroughs, medical simulation seems to have only started to find a permanent place in medical education in the late 20th century, and permanent use in the training of medical personnel only took place after 2000.